Suppr超能文献

使用血流导向支架治疗颈眼动脉瘤后的脉络膜和视网膜解剖学反应。

Choroidal and retinal anatomical response following treatment of carotid-ophthalmic aneurysms with flow diverter stents.

作者信息

Biberoğlu Çelik Esra, Haidar Hassan, Eraslan Muhsin, Baltacioglu Feyyaz

机构信息

Department of Ophthalmology, Marmara University Pendik Educational and Research Hospital, Istanbul, Turkey.

School of Medicine, Marmara University, Istanbul, Turkey.

出版信息

Photodiagnosis Photodyn Ther. 2022 Dec;40:103117. doi: 10.1016/j.pdpdt.2022.103117. Epub 2022 Sep 13.

Abstract

BACKGROUND

Flow diverter stents(FDSs) are recent additions to the endovascular armament for treating ophthalmic segment aneurysms(OSA). In our study we evaluated the long-term effect of FDS placement on multiple Optical Coherence Tomography(OCT) findings, best corrected visual acuity(BCVA) and intra-ocular pressure(IOP).

METHODS

A prospective cohort study was conducted in 35 patients treated with a single FDS placement for OSA, between 2013 and 2018. Spectral-domain OCT was used to measure retinal nerve fiber layer thickness, ganglion cell complex thickness, subfoveal choroidal thickness(SFCT), and other stereometric parameters. Choroidal Vascularity Index(CVI) in a 1.5 mm wide subfoveal choroidal area was calculated. BCVA and IOP were also assessed. These measurements, at final follow up, were compared to the untreated fellow eye to evaluate the long-term effect of FDS placement.

RESULTS

This study included 70 eyes from 35 patients (100% female) with a mean age of 54.9 ± 9.8 years and mean follow-up period of 37.3 ± 18.9 months. No ophthalmic artery occlusion was encountered. The mean CVI was significantly higher in the stented side compared to the fellow normal eye (66.90±1.95 vs 65.05±1.93, p=.001) while mean SFCT was significantly reduced (251.23±68.54 vs 288.78±78.95, p=.037). Differences in the remaining studied parameters did not reach statistical significance. The difference in BCVA between stented and fellow normal eyes was also not significant (0.057±0.213 vs 0.060±0.214, p=.977 in logMAR).

CONCLUSION

Treatment with FDSs did not cause permanent visual damage. This study is the first to report a decrease in SFCT with a compensatory increase in CVI following FDS placement for OSA.

摘要

背景

血流导向支架(FDS)是治疗眼动脉段动脉瘤(OSA)的血管内治疗手段中的新成员。在我们的研究中,我们评估了FDS置入对多项光学相干断层扫描(OCT)结果、最佳矫正视力(BCVA)和眼压(IOP)的长期影响。

方法

对2013年至2018年间35例接受单次FDS置入治疗OSA的患者进行了一项前瞻性队列研究。使用光谱域OCT测量视网膜神经纤维层厚度、神经节细胞复合体厚度、黄斑下脉络膜厚度(SFCT)和其他立体测量参数。计算黄斑下1.5mm宽脉络膜区域的脉络膜血管指数(CVI)。还评估了BCVA和IOP。在最终随访时,将这些测量结果与未治疗的对侧眼进行比较,以评估FDS置入的长期影响。

结果

本研究纳入了35例患者的70只眼(100%为女性),平均年龄为54.9±9.8岁,平均随访期为37.3±18.9个月。未遇到眼动脉闭塞。与对侧正常眼相比,支架置入侧的平均CVI显著更高(66.90±1.95对65.05±1.93,p = 0.001),而平均SFCT显著降低(251.23±68.54对288.78±78.95,p = 0.037)。其余研究参数的差异未达到统计学意义。支架置入眼与对侧正常眼之间的BCVA差异也不显著(logMAR中为0.057±0.213对0.060±0.214,p = 0.977)。

结论

FDS治疗未导致永久性视力损害。本研究首次报告了OSA患者FDS置入后SFCT降低且CVI代偿性增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验